Plain-English translation of NCT07231419 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called to see if it can safely reduce the pain that comes from nerve damage caused by diabetes. About 734 people with diabetic nerve pain in their legs will participate. Half will receive the medication, and half will receive a placebo (a pill with no active medicine) to compare how well the treatment works.
Nerve pain from diabetes can be very difficult to treat with existing medications, and many people still suffer from significant pain. This trial is exploring whether this medication offers a new option for people dealing with this type of chronic pain.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be randomly assigned to either take the medication or a placebo, and you won't know which one you're getting. You'll take your assigned treatment regularly and track your pain levels daily using a simple rating scale. You'll have study visits where the doctors will check how you're doing and ask about any side effects you've experienced.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States